RANKINGS

POPULAR STOCKS

UBC Medical Indonesia Tbk.

Jakarta Stock Exchange:LABS.JK

Location

Indonesia

Market Cap

USD 32.05 M

Share Price

USD 0.01

Avg Daily Volume

1,042,736

Change (1 day)

-2.29%

Change (1 year)

Change (YTD)

11.71%

UBC Medical Indonesia Tbk. Gross Profit Margin for the year ending December 31, 2024: 30.89%

UBC Medical Indonesia Tbk. Gross Profit Margin is 30.89% for the year ending December 31, 2024, a -9.20% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • UBC Medical Indonesia Tbk. Gross Profit Margin for the year ending December 31, 2023 was 34.02%, a 4.84% change year over year.
  • UBC Medical Indonesia Tbk. Gross Profit Margin for the year ending December 31, 2022 was 32.45%, a -20.58% change year over year.
  • UBC Medical Indonesia Tbk. Gross Profit Margin for the year ending December 31, 2021 was 40.86%.
Key data
Date Gross Profit Margin EBIT Margin EBITDA Margin Net Income Margin
Market news
Jakarta Stock Exchange: LABS.JK

UBC Medical Indonesia Tbk.

CEO Mr. Franciscus Xaverius Yoshua Raintjung
IPO Date July 10, 2024
Location Indonesia
Headquarters Etana Building
Employees 62
Sector 🏥 Health Care
Industries
Telehealth
🧬 Biotechnology
💊 Drugstores & Retail Pharmacies
🩺 Medical Instruments
Description

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.

StockViz Staff

June 16, 2025

Any question? Send us an email